In cell proliferation experiments, both the selective β1-AR antagonist ATE and β2-AR antagonist ICI significantly blocked E-induced cell proliferation (Fig. 6A), indicating the involvement of both β-AR subtypes in promoting tumor cell proliferation. Here, ADRB2 is linked to neoplasm.